Turning point or tipping point: new FDA draft guidances and the future of DTC advertising.
Pitts
Peter J
PJ
US Food and Drug Administration, Rockville, Maryland, USA. peter.pitts@fda.gov
D000329:Advertising / Q000331:legislation & jurisprudence* / Q000379:methods / Q000639:trends; D003256:Community Participation; D004345:Drug Industry / Q000458:organization & administration; D006801:Humans; D004364:Pharmaceutical Preparations; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations